These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 9131631)

  • 21. Chiral-based therapeutics.
    Persidis A
    Nat Biotechnol; 1997 Jun; 15(6):594-5. PubMed ID: 9181585
    [No Abstract]   [Full Text] [Related]  

  • 22. Overcoming the challenges in the pharma/biotech industry.
    Graul AI; Prous JR
    Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A brave new medicine. A conversation with William Haseltine.. Interview by Joe Flower.
    Hasetine W
    Health Forum J; 1999; 42(4):28-30, 61-5. PubMed ID: 10539016
    [No Abstract]   [Full Text] [Related]  

  • 24. Syrrx acquisition signals maturation of structure-based discovery.
    Ratner M
    Nat Biotechnol; 2005 Apr; 23(4):400. PubMed ID: 15815651
    [No Abstract]   [Full Text] [Related]  

  • 25. New drugs and changing disease paradigms.
    Crooke ST
    Nat Biotechnol; 1996 Mar; 14(3):238-41. PubMed ID: 9630876
    [No Abstract]   [Full Text] [Related]  

  • 26. Gene therapy: cursed or inching towards credibility?
    Branca MA
    Nat Biotechnol; 2005 May; 23(5):519-21. PubMed ID: 15877060
    [No Abstract]   [Full Text] [Related]  

  • 27. Genomic sciences and the medicine of tomorrow.
    Drews J
    Nat Biotechnol; 1996 Nov; 14(11):1516-8. PubMed ID: 9634812
    [No Abstract]   [Full Text] [Related]  

  • 28. Designs that enrich lives.
    Link A; Stark H
    Arch Pharm (Weinheim); 2007 Oct; 340(10):509-10. PubMed ID: 17912676
    [No Abstract]   [Full Text] [Related]  

  • 29. Advice for partnering with pharma.
    Howard K
    Nat Biotechnol; 2004 Nov; 22(11):1477-9. PubMed ID: 15586421
    [No Abstract]   [Full Text] [Related]  

  • 30. Signal transduction as a drug-discovery platform.
    Nat Biotechnol; 2000 Oct; 18 Suppl():IT37-9. PubMed ID: 11221714
    [No Abstract]   [Full Text] [Related]  

  • 31. Signal transduction as a drug-discovery platform.
    Persidis A
    Nat Biotechnol; 1998 Nov; 16(11):1082-3. PubMed ID: 9831041
    [No Abstract]   [Full Text] [Related]  

  • 32. Advancing in the face of conventional wisdom.
    Lanzara R
    Drug Discov Today; 2004 Feb; 9(3):110-1. PubMed ID: 14960386
    [No Abstract]   [Full Text] [Related]  

  • 33. BIO 2006 Annual International Convention. Innovations in biotech in China and Italy.
    Tear S; Zarkowska T
    IDrugs; 2006 Jun; 9(6):386-9. PubMed ID: 16752303
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibacterial and antifungal drug discovery.
    Nat Biotechnol; 2000 Oct; 18 Suppl():IT24-6. PubMed ID: 11221710
    [No Abstract]   [Full Text] [Related]  

  • 35. Sugar added. Cheaper, better protein drugs through sweetening.
    Gibbs W
    Sci Am; 2003 Jul; 289(1):23-4. PubMed ID: 12840940
    [No Abstract]   [Full Text] [Related]  

  • 36. Peptides: isolation, production, and use in India.
    Nagaraj R
    Biotechnol J; 2009 Mar; 4(3):329-34. PubMed ID: 19156729
    [No Abstract]   [Full Text] [Related]  

  • 37. Deal-making trends in oncology.
    Moore K; Walker J
    Nat Rev Drug Discov; 2009 Aug; 8(8):604. PubMed ID: 19644466
    [No Abstract]   [Full Text] [Related]  

  • 38. Proteomics.
    Nat Biotechnol; 2000 Oct; 18 Suppl():IT45-6. PubMed ID: 11221717
    [No Abstract]   [Full Text] [Related]  

  • 39. Cancer multidrug resistance.
    Nat Biotechnol; 2000 Oct; 18 Suppl():IT18-20. PubMed ID: 11221708
    [No Abstract]   [Full Text] [Related]  

  • 40. Arthritis.
    Nat Biotechnol; 2000 Oct; 18 Suppl():IT12-4. PubMed ID: 11221706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.